CABTREO not checked
Bausch Health Americas, Inc. · IDP-126
FollowEvery change as it happens, and a Monday email
Trials
1 active
5 in total
Targets
—
None known yet
What this is
- How it works
- How it works isn't classified yet
- How it’s given
- “The study drug will be applied topically to the treatment areas at home, each the morning, for a period of 12 weeks, with the exception of study visit days (baseline \[Day 1\], and Days 14, 15 \[PK substudy only\], 28, 29 \[PK substudy only\], 56, and 84) where study drug will be applied by the participants after the study visit is completed at the study center. The study drug will be applied as…”In the company’s words, NCT07524946 on ClinicalTrials.gov
- Tested for
- Acne Vulgaris
- Main trialPhase 4
- “This study is to evaluate the safety, pharmacokinetics, and treatment effect for topically applied CABTREO lotion in pediatric participants ages 9 to 11 years, 11 months with Acne Vulgaris.”In the company’s words, NCT07524946 on ClinicalTrials.gov
- Other names
- IDP-126
- Copy of
- Epiduo (Galderma Labs LP)Tested side by side with the original in NCT04892706
Other drugs for Acne Vulgaris
- TrifaroteneGalderma R&D · Phase 3
- Cyproterone Acetate and Ethinyl EstradiolEurofarma Laboratorios S.A. · Phase 3
- DenifanstatSagimet Biosciences Inc. · Ascletis · Phase 3
- ClascoteroneZhejiang Sunshine Mandi Pharmaceutical Co.,Ltd. · Phase 3
- B244AOBiome LLC · Phase 2
- Acne mRNA vaccineSanofi · Phase 1/2
Coming up1
- Dec 2027Phase 4 trial completes · ClinicalTrials.gov
Changes0
Last 90 daysNo changes yet. We started recording changes on 6 Nov 2026.
Trials5
| Trial | Phase | Completes | What it tests |
|---|---|---|---|
| Phase 4Recruiting | Dec 2027 | Study to Assess Safety, Pharmacokinetics, and Treatment Effect of Cabtreo | |
| Phase 3Completed | 18 Jan 2021 | Clinical Study Comparing the Efficacy and Safety of IDP-126 Gel in the Treatment of Acne Vulgaris | |
| Phase 3Completed | 18 Mar 2021 | Clinical Study Comparing the Efficacy and Safety of IDP-126 Gel in the Treatment of Acne Vulgaris | |
| Phase 2Completed | 23 Apr 2019 | A Phase 2, Multicenter, Randomized, Double-Blind, Vehicle Controlled, Parallel-Group, Clinical Study in the Treatment of Acne Vulgaris | |
| Phase 2Completed | 28 Sep 2022 | Study to Compare the Safety and Efficacy of IDP-126 Gel to Epiduo® Forte Gel and Vehicle Gel |
A trial in both registries shows both numbers.
About
- Sources
- ClinicalTrials.gov updated 19 Nov 2026 · EU trials register (CTIS) updated 19 Nov 2026 · openFDA updated 19 Nov 2026